This study describes a quality improvement program that included chart review of patients taking high-dose opioids for noncancer pain and targeted feedback to clinicians with management recommendations. The program resulted in a decrease in overall opioid use as well as a reduction in coprescribing of benzodiazepines and opioids. Patient adherence to visits with their primary physician remained stable during the study period.